日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

An Improved (211)At-Labeled Agent for PSMA-Targeted α-Therapy

一种改进的（211）At标记的PSMA靶向α疗法药物

期刊:
影响因子:
doi:10.2967/jnumed.121.262098
Mease, Ronnie C; Kang, Choong Mo; Kumar, Vivek; Banerjee, Sangeeta Ray; Minn, Il; Brummet, Mary; Gabrielson, Kathleen L; Feng, Yutian; Park, Andrew; Kiess, Ana P; Sgouros, George; Vaidyanathan, Ganesan; Zalutsky, Michael R; Pomper, Martin G
发表日期：2022
文献求助 收藏

Scalable Purification of Plasmid DNA Nanoparticles by Tangential Flow Filtration for Systemic Delivery

利用切向流过滤法对质粒DNA纳米颗粒进行可扩展纯化，用于全身递送

期刊:ACS Applied Materials & Interfaces
影响因子:8.2
doi:10.1021/acsami.1c05750
Liu, Heng-Wen; Hu, Yizong; Ren, Yong; Nam, Hwanhee; Santos, Jose Luis; Ng, Shirley; Gong, Like; Brummet, Mary; Carrington, Christine A; Ullman, Christopher G; Pomper, Martin G; Minn, Il; Mao, Hai-Quan
发表日期：2021
文献求助 收藏

Quantifying dynamic range in red blood cell energetics: Evidence of progressive energy failure during storage

量化红细胞能量学动态范围：储存过程中能量逐渐衰竭的证据

期刊:Transfusion
影响因子:2
doi:10.1111/trf.16395
Rogers, Stephen C; Ge, Xia; Brummet, Mary; Lin, Xue; Timm, David D; d'Avignon, Andre; Garbow, Joel R; Kao, Jeff; Prakash, Jaya; Issaian, Aaron; Eisenmesser, Elan Z; Reisz, Julie A; D'Alessandro, Angelo; Doctor, Allan
红细胞
细胞生物学
发表日期：2021
文献求助 收藏

Preclinical Evaluation of (213)Bi- and (225)Ac-Labeled Low-Molecular-Weight Compounds for Radiopharmaceutical Therapy of Prostate Cancer

前列腺癌放射性药物治疗中(213)Bi和(225)Ac标记的小分子化合物的临床前评价

期刊:
影响因子:
doi:10.2967/jnumed.120.256388
Banerjee, Sangeeta Ray; Lisok, Ala; Minn, Il; Josefsson, Anders; Kumar, Vivek; Brummet, Mary; Boinapally, Srikanth; Brayton, Cory; Mease, Ronnie C; Sgouros, George; Hobbs, Robert F; Pomper, Martin G
肿瘤
前列腺癌
肿瘤免疫
发表日期：2021
文献求助 收藏

Preclinical Evaluation of (203/212)Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate Cancer

前列腺癌靶向放射性药物治疗中(203/212)Pb标记低分子量化合物的临床前评价

期刊:
影响因子:
doi:10.2967/jnumed.119.229393
Banerjee, Sangeeta Ray; Minn, Il; Kumar, Vivek; Josefsson, Anders; Lisok, Ala; Brummet, Mary; Chen, Jian; Kiess, Ana P; Baidoo, Kwamena; Brayton, Cory; Mease, Ronnie C; Brechbiel, Martin; Sgouros, George; Hobbs, Robert F; Pomper, Martin G
肿瘤
前列腺癌
肿瘤免疫
发表日期：2020
文献求助 收藏

Kinetic Control in Assembly of Plasmid DNA/Polycation Complex Nanoparticles.

质粒DNA/聚阳离子复合物纳米粒子组装的动力学控制

期刊:ACS Nano
影响因子:16
doi:10.1021/acsnano.9b03334
Hu Yizong, He Zhiyu, Hao Yue, Gong Like, Pang Marion, Howard Gregory P, Ahn Hye-Hyun, Brummet Mary, Chen Kuntao, Liu Heng-Wen, Ke Xiyu, Zhu Jinchang, Anderson Caleb F, Cui Honggang, Ullman Christopher G, Carrington Christine A, Pomper Martin G, Seo Jung-Hee, Mittal Rajat, Minn Il, Mao Hai-Quan
其它
发表日期：2019
文献求助 收藏

(177)Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy

用于PSMA靶向放射性药物治疗的(177)Lu标记的小分子药物

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-019-04434-0
Banerjee, Sangeeta Ray; Kumar, Vivek; Lisok, Ala; Chen, Jian; Minn, Il; Brummet, Mary; Boinapally, Srikanth; Cole, Michael; Ngen, Ethel; Wharram, Bryan; Brayton, Cory; Hobbs, Robert F; Pomper, Martin G
发表日期：2019
文献求助 收藏

Evaluation of (111)In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen

对 (111)In-DOTA-5D3（一种用于前列腺特异性膜抗原放射免疫疗法的替代 SPECT 成像剂）的评估

期刊:
影响因子:
doi:10.2967/jnumed.118.214403
Banerjee, Sangeeta Ray; Kumar, Vivek; Lisok, Ala; Plyku, Donika; Nováková, Zora; Brummet, Mary; Wharram, Bryan; Barinka, Cyril; Hobbs, Robert; Pomper, Martin G
免疫/内分泌
发表日期：2019
文献求助 收藏

Airway glycomic and allergic inflammatory consequences resulting from keratan sulfate galactose 6-O-sulfotransferase (CHST1) deficiency

角质硫酸半乳糖6-O-磺基转移酶（CHST1）缺乏症引起的呼吸道糖组学和过敏性炎症后果

期刊:Glycobiology
影响因子:3.3
doi:10.1093/glycob/cwy025
Kumagai, Tadahiro; Kiwamoto, Takumi; Brummet, Mary E; Wu, Fan; Aoki, Kazuhiro; Zhu, Zhou; Bochner, Bruce S; Tiemeyer, Michael
炎症/感染
CHST1
炎症
发表日期：2018
文献求助 收藏

(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy

(2S)-2-(3-(1-羧基-5-(4-211At-Astatobenamido)戊基)脲基)-戊二酸用于PSMA靶向α粒子放射性药物治疗

期刊:
影响因子:
doi:10.2967/jnumed.116.174300
Kiess, Ana P; Minn, Il; Vaidyanathan, Ganesan; Hobbs, Robert F; Josefsson, Anders; Shen, Colette; Brummet, Mary; Chen, Ying; Choi, Jaeyeon; Koumarianou, Eftychia; Baidoo, Kwamena; Brechbiel, Martin W; Mease, Ronnie C; Sgouros, George; Zalutsky, Michael R; Pomper, Martin G
发表日期：2016
文献求助 收藏